In parallel, the pro-inflammatory marker sphingosine kinase 2 (SK2) promotes the activation of MYC in murine models of B-ALL by increasing its acetylation profile. This evidence concerns the gene SPHK2 and precursor B-cell acute lymphoblastic leukemia.